期刊文献+

循环热灌注化疗治疗恶性腹腔积液疗效观察 被引量:8

Clinical observation on cycle thermochemotherapy of intraperitoneal perfusion for malignant peritoneal effusion
下载PDF
导出
摘要 目的:观察循环热灌注化疗治疗恶性腹腔积液的临床疗效。方法:将病理检查确诊的恶性腹腔积液患者56例,随机分为试验组(29例)、对照组(27例)。所有患者经腹腔穿刺及灌洗术后,试验组行腹腔内循环热灌注化疗,对照组仅行热灌注化疗,观察疗效及不良反应。结果:试验组腹水治疗的总有效率为93.1%;对照组为66.7%,有显著性差异(P<0.025)。试验组治疗过程中多汗发生率(89.7%)高于对照组(29.6%),有显著性差异(P<0.05)。结论:腹腔内循环热灌注化疗治疗恶性腹腔积液疗效好、操作简单、不良反应少、患者耐受性好、优势明显。 Objective: To evaluate the efficacy of cycle thermochemotherapy of intraperitoneal perfusion for malignant peritoneal effusion. Methods:Fifty six cases with malignant peritoneal effusion were randomly divided into two groups. After abdominal paracentesis and lavation ,29 cases were treated with cycle thermochemotherapy of intraperitoneally perfusion and 27 cases were treated with thermochemotherapy of intraperitoneally perfusion as control. Then the treatment effect and toxicities were assessed. Results: The response rate was 93.1% in treated group and 66.7% in the control group (P 〈 0. 025 ) . The hyperhidrosis more frequently happened in therapy group (89.7%) than in control group (29.6 % ) ( P 〈 0.05 ) . Conclusion: Cycle thermochemotherapy of intraperitoneal perfusion for malignant peritoneal effusion is an effective and well tolerated method for the malignant peritoneal effusion with slight side - effect .
出处 《现代肿瘤医学》 CAS 2009年第11期2185-2187,共3页 Journal of Modern Oncology
关键词 恶性腹腔积液 温热疗法 热灌注 顺铂 malignant pleural effusion thermotherapy perfusion cisplatine
  • 相关文献

参考文献4

二级参考文献20

  • 1林世寅,胡自省,毛慧生,张天泽.第七届国际肿瘤热疗会议概述[J].中国肿瘤临床,1996,23(9):671-675. 被引量:11
  • 2林世寅 李瑞英.现代肿瘤热疗学[M].天津:学苑出版社,1998.15-17.
  • 3李继华.恶性肿瘤的热化疗.全国第五届热疗学术会论文汇编[M].烟台,1993,3..
  • 4Hofstra LS,deVries EG,Mulder NH,et al.Intraperitoneal chemotherapy in ovarian cancer[J].Cancer Treat Rev,2000,26:133-143.
  • 5Shen P,Levine EA,Hall J,et al.Intraperitoneal hyperthermic chemotherapy(IPHC)with mitomycin C(MMC)after cytoreductive surgery(CS)for patients with peritoneal carcinomatosis:predictors of long term survival[J].Proc Ann Meeting Am Soc Clin Oncol,2001,674.
  • 6Hohenberger P,Latz E,Kettelhack C,et a1.Pentoxifyllin attenuates the systemic inflammatory response induces during isolated limb perfusion with recombinant human tumor necrosis factor-alpha a nd melphalan[J].Ann Surg Oncol,2003,10(5):562-568.
  • 7Terlikowski S,Sulkowska M,Nowak HF.The effect of recombinant human tumor necrosis factor-alpha on Ehrlich ascites tumor growthE[J].J Environ Pathol Toxicol Oncol,2002,21(1):87-92.
  • 8Spadaro M,Lanzardo S,Curcio C,et a1.Immunological inhibition of carcinogenesis[J].Cancer Immunol Immunother,2004,53(3):204-216.
  • 9Falk MH,Issels RD.Hypertherrnia in oncology[J].Int J Hyperthermia,2001,17(1):1-18.
  • 10Mussa A,Sandrucci S,Zanon C.Intraoperative chemohypertherrnia for advanced gastric cancer:a new procedure with closed abdomen and previously constructed anastomosis[J].Tumor,2001,87(4):18-20.

共引文献62

同被引文献73

  • 1Ba, Ming-Chen,Cui, Shu-Zhong,Lin, Sheng-Qu,Tang, Yun-Qiang,Wu, Yin-Bing,Wang, Bin,Zhang, Xiang-Liang.Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites[J].World Journal of Gastroenterology,2010,16(15):1901-1907. 被引量:50
  • 2吴清艺,楚建设.顺铂腹腔内滴灌联合全身化疗治疗晚期胃癌[J].中国医院用药评价与分析,2007,7(1):72-74. 被引量:8
  • 3孙燕.临床肿瘤内科手册[M].5版.北京:人民卫生出版社,2008:597.
  • 4Kelly H, Goldberg RM. Systemic therapy for metastatic color- ectal cancer: current options, current evident[J]. J Clin Oncol, 2005, 23(20):4553-4560.
  • 5Watanabe T, Hirono H, Hasegawa K, et al. Advanced gastric cancer patient with peritonitis carcinomatosa successfully treated with a combination therapy of paclitaxel and TS-1, but relapsed with multiple bone metastasis and died from rapidly progressive meningitis carcinomatosa advanced gastric cancer with metachro nous peritonitis carcinomatosa and meningitis carcinomatosa[J].Intern Med, 2009, 48(3):151-156.
  • 6Erito M, Mariko S, Hideyuki S, et al. Feasibility study of post- operative intraperitoneal hyperthermochemotherapy by radiofre quency capacitive heating system for advanced gastric cancer with peritoneal seeding[J].Int J Hyperthermia, 2007,23 (6) : 493-500.
  • 7Todd RC, Lippard ST. Inhibition of transcription by platinum antitumor compounds[J]. Metallomics, 2009, 1(14) :280-291.
  • 8Los G, Mutsaers PHA, Vander WTF, et al. Direct diffusion of cisdiammine dichloroplatinum( Ⅱ ) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparaaion with systemic chemotherapy[J]. Cancer Res, 1989,49 (12) : 3380-3392.
  • 9Hong JC, Sun YR, Chong KJ, et al. Docetaxel versus paclitaxel combined with 5-fu and leucovorin in advanced gastric cancer: combined analysis of two phase Ⅱ trials[J]. Cancer Res Treat, 2009, 41(4) :196-203.
  • 10Parkin DM. Global cancer statistics in the year 2000. Lancet oncol,2001, 2:533-543.

引证文献8

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部